CIK 0000313143
- Large accelerated filer
HAEMONETICS CORP
Sign in to watch- Ticker
- HAE
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Apr 3
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 042882273
- Phone
- +1 781-848-7100
- Business address
- 125 SUMMER STREET, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $101,148
- in 1 filing
Net −$101,148. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-04-20 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Sale | −4,902 | $41.55 | $204K | 37,833 |
| 2015-04-20 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −4,902 | $41.55 | $204K | 19,608 |
| 2015-04-13 | Helsel Dave EVP, Global Manufacturing | Returned to the company | −302 | $43.73 | $13K | 13,216 |
| 2015-04-01 | CONCANNON BRIAN President & CEO | Exercise or conversion | +4,765 | $27.28 | $130K | 151,805 |
| 2015-04-01 | CONCANNON BRIAN President & CEO | Sale | −4,765 | $44.51 | $212K | 147,040 |
| 2015-04-01 | CONCANNON BRIAN President & CEO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −4,765 | $44.51 | $212K | 28,586 |
| 2015-03-27 | HANLON SUSAN M VP Finance | Exercise or conversion | +7,000 | $26.47 | $185K | 25,503 |
| 2015-03-27 | HANLON SUSAN M VP Finance | Sale | −7,000 | $43.46 | $304K | 18,503 |
| 2015-03-27 | HANLON SUSAN M VP Finance | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −7,000 | $43.46 | $304K | 4,000 |
| 2015-03-20 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Exercise or conversion | +4,902 | $26.32 | $129K | 42,493 |
| 2015-03-20 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Sale | −4,902 | $44.26 | $217K | 37,591 |
| 2015-03-20 | LINDOP CHRISTOPHER J CFO & EVP Business Development | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −4,902 | $44.26 | $217K | 24,510 |
| 2015-03-10 | FOOTE SUSAN BARTLETT Director | Exercise or conversion | +11,328 | $29.23 | $331K | 23,661 |
| 2015-03-10 | FOOTE SUSAN BARTLETT Director | Sale | −11,328 | $43.84 | $497K | 12,333 |
| 2015-03-10 | FOOTE SUSAN BARTLETT Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −11,328 | $43.84 | $497K | 0 |
| 2015-03-05 | GELBMAN RONALD G Director | Exercise or conversion | +11,328 | $29.23 | $331K | 52,895 |
| 2015-03-05 | GELBMAN RONALD G Director | Sale | −7,707 | $44.76 | $345K | 45,188 |
| 2015-03-05 | GELBMAN RONALD G Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −11,328 | $44.76 | $507K | 0 |
| 2015-03-04 | MERRIMAN RONALD Director | Exercise or conversion | +2,500 | $27.24 | $68K | 14,605 |
| 2015-03-04 | MERRIMAN RONALD Director | Sale | −2,500 | $43.80 | $109K | 12,105 |
Page 53 of 59 · 1,162 trades